A critical evaluation of microRNA biomarkers in non-neoplastic disease

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Haider, Baqer A ^a   Baras, Alexander S ^a   McCall, Matthew N ^b   Hertel, Joshua A ^a   Cornish, Toby C ^a   Halushka, Marc K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 122; MICRORNA 126; MICRORNA 146A; MICRORNA 155; MICRORNA 16; MICRORNA 21; MICRORNA 223;

ARTICLE; CELL DAMAGE; GENE EXPRESSION; HEART DISEASE; HEART INFARCTION; HEPATITIS B; HEPATITIS C; LIVER DISEASE; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEPSIS; AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG DISEASE; METABOLISM; MONONUCLEAR CELL; PATHOLOGY; PROGNOSIS;

AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER DISEASES; LUNG DISEASES; MICRORNAS; PROGNOSIS;

EID: 84896277946     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089565     Document Type: Article

References (51)

1. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
2. Griffiths-Jones S (2004) The microRNA Registry. Nucleic Acids Res 32: D109-111.
3. McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, et al. (2011) MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics 4: 78.
4. Zhan M, Miller CP, Papayannopoulou T, Stamatoyannopoulos G, Song CZ (2007) MicroRNA expression dynamics during murine and human erythroid differentiation. Exp Hematol 35: 1015-1025. (Pubitemid 46921304)
5. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581. (Pubitemid 41266486)
6. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233. (Pubitemid 43177239)
7. Das S, Ferlito M, Kent OA, Fox Talbot K, Wang R, et al. (2012) Nuclear miRNA Regulates the Mitochondrial Genome in the Heart. Circ Res. 110: 1596-1603.
8. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, et al. (2007) Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659. (Pubitemid 47214727)
9. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 3: e3694.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
11. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
12. Biomarkers Definitions Working G (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69: 89-95.
13. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, et al. (2012) Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila) 5: 492-497.
14. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An analysis of human microRNA and disease associations. PLoS One 3: e3420.
15. Wu Z, Aryee MJ (2010) Subset quantile normalization using negative control features. J Comput Biol 17: 1385-1395.
16. McCall MN, Bolstad BM, Irizarry RA (2010) Frozen robust multiarray analysis (fRMA). Biostatistics 11: 242-253.
17. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127. (Pubitemid 44906106)
18. Munding JB, Adai AT, Maghnouj A, Urbanik A, Zollner H, et al. (2011) Global microRNA expression profiling of microdissected tissues identifies miR-135b as a novel biomarker for pancreatic ductal adenocarcinoma. Int J Cancer 131: E86-96.
19. Kotlabova K, Doucha J, Hromadnikova I (2011) Placental-specific microRNA in maternal circulation-identification of appropriate pregnancy-associated microRNAs with diagnostic potential. J Reprod Immunol 89: 185-191.
20. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, et al. (2010) Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 37: 2516-2522.
21. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, et al. (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4: 446-454.
22. Seglen PO (1997) Why the impact factor of journals should not be used for evaluating research. BMJ 314: 498-502.
23. Merkerova M, Belickova M, Bruchova H (2008) Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 81: 304-310.
24. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, et al. (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17: 662-673.
25. WuZS,Wang CQ, Xiang R, Liu X, Ye S, et al. (2012) Loss ofmiR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 12: 51.
26. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, et al. (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107: 810-817.
27. Bonifacio LN, Jarstfer MB (2010) MiRNA profile associated with replicative senescence, extended cell culture, and ectopic telomerase expression in human foreskin fibroblasts. PLoS One 5: e12519.
28. Boon RA, Seeger T, Heydt S, Fischer A, Hergenreider E, et al. (2011) MicroRNA-29 in aortic dilation: implications for aneurysm formation. Circ Res 109: 1115-1119.
29. Fasanaro P, D'Alessandra Y, Di Stefano V,Melchionna R, Romani S, et al. (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283: 15878-15883.
30. Grueter CE, van Rooij E, Johnson BA, DeLeon SM, Sutherland LB, et al. (2012) A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149: 671-683.
31. Mendell JT, Olson EN (2012) MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187.
32. Ji R, Cheng Y, Yue J, Yang J, Liu X, et al. (2007) MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res 100: 1579-1588. (Pubitemid 46897261)
33. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
34. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, et al. (2010) miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207: 1589-1597.
35. Zarjou A, Yang S, Abraham E, Agarwal A, Liu G (2011) Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol 301: F793-801.
36. Haider KH, Idris NM, Kim HW, Ahmed RP, Shujia J, et al. (2010) MicroRNA-21 is a key determinant in IL-11/Stat3 anti-apoptotic signalling pathway in preconditioning of skeletal myoblasts. Cardiovasc Res 88: 168-178.
37. Jazbutyte V, Thum T (2010) MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 11: 926-935.
38. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, et al. (2008) miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284.
39. Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, et al. (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271.
40. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105: 1516-1521. (Pubitemid 351346546)
41. Kirschner MB, Kao SC, Edelman JJ, Armstrong NJ, Vallely MP, et al. (2011) Haemolysis during sample preparation alters microRNA content of plasma. PLoS One 6: e24145.
42. Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, et al. (2013) Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One 8: e64795.
43. Wang K, Yuan Y, Cho JH, McClarty S, Baxter D, et al. (2012) Comparing the MicroRNA spectrum between serum and plasma. PLoS One 7: e41561.
44. Huang Z, Huang D, Ni S, Peng Z, Sheng W, et al. (2010) Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 127: 118-126.
45. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, et al. (2011) Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 91: 579-587.
46. Friedman EB, Shang S, Fleming NH, Vega-Saenz de Miera E, Hernando E, et al. (2012) Expression of miR-16 is not a suitable reference for analysis of serum microRNAs in melanoma patients. J Biomed Sci and Eng 5: 647-651.
47. McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A (2011) Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 57: 833-840.
48. Zheng HW, Wang YL, Lin JX, Li N, Zhao XQ, et al. (2012) Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage. CNS Neurosci Ther 18: 1003-1011.
49. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13: 358-369.
50. Hua YJ, Tu K, Tang ZY, Li YX, Xiao HS (2008) Comparison of normalization methods with microRNA microarray. Genomics 92: 122-128.
51. Witwer KW (2013) Data submission and quality in microarray-based microRNA profiling. Clin Chem 59: 392-400.